Viewing Study NCT02012933


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-04-06 @ 3:23 PM
Study NCT ID: NCT02012933
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2019-12-11
First Post: 2013-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Sponsor: Oregon Health and Science University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module